Brief: Everest Organics says FDA finds 1 observation during inspection of co's facility
06/03/2017 06:28
March 6 (Reuters) - Everest Organics Ltd EVER.BO
* Says USFDA inspected our facility at Aroor village, from
27.02.2017 to 03.03.2017
* Says there is only one observation
* Says believe observation to be of minor in nature
* Says corrective & preventive action for this observation
will be presented to USFDA shortly
Source text: http://bit.ly/2mrIk3l
Further company coverage: EVER.BO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Everest Organics
See all newsBrief: Everest Organics Gets Korea Drug Master File Approval For Its Rabeprazole Sodium API
Brief: Everest Organics To Consider Fund Raising
Brief: Everest Organics Names Srikakarlapudi Sirisha As MD
Brief: Everest Organics Gets Permanent Revocation Of Factory Closure Order
India's Everest Organics starts making ingredient for Merck's COVID-19 pill (updated)